FA
ELGX

FDx Advisors’s Endologix Inc ELGX Stock Holding History

FDx Advisors’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-1,288
Closed -$160K – 974
2016
Q2 		$160K Buy
1,288
+203
+19% +$23.3K 0.01% 858
2016
Q1 		$91K Buy
1,085
+77
+8% +$6.35K ﹤0.01% 880
2015
Q4 		$100K Buy
+1,008
New +$108K ﹤0.01% 851

Other funds holding ELGX

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return

FDx Advisors's ELGX Position: Q3 2016 in Review

FDx Advisors sold out of Endologix Inc (ELGX) in Q3 2016, closing a stake of 1,288 shares — an estimated $160K sold.

FDx Advisors first reported a position in ELGX in Q4 2015 and held it in 3 quarters. The position peaked at $160K in Q2 2016. 152 funds tracked by Wall St. Rank hold ELGX as of Q3 2016.

  • FDx Advisors reported no remaining Endologix Inc position as of Q3 2016 after selling out during the quarter.
  • FDx Advisors sold 1,288 Endologix Inc shares in Q3 2016, an estimated $160K.
  • FDx Advisors first reported a position in Endologix Inc in Q4 2015 and held it in 3 quarters.
  • FDx Advisors's Endologix Inc position peaked at $160K in Q2 2016.
  • 152 funds tracked by Wall St. Rank held Endologix Inc as of Q3 2016.

Based on FDx Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.